Leadership Overview
Morepen has 4 executives leading key functions including marketing, operations, business development, and international growth.
Focused on delivering high-quality pharmaceutical solutions, Morepen prioritizes innovation and global accessibility to improve health outcomes for millions of consumers across diverse international markets.
Focused on delivering high-quality pharmaceutical solutions, Morepen prioritizes innovation and global accessibility to improve health outcomes for millions of consumers across diverse international markets.
Leadership Roles at Morepen
Amita Sharma - Chief Operating Officer
Amita Sharma, the Chief Operating Officer at Morepen, manages all manufacturing operations and supply chain logistics across state-of-the-art facilities. Overseeing the production of Active Pharmaceutical Ingredients and finished formulations, the Chief Operating Officer ensures strict adherence to USFDA and WHO GMP quality standards. This leadership role involves optimizing manufacturing efficiency to meet the demands of over 80 export markets. By streamlining internal processes, Amita Sharma reduces operational costs while maintaining high product integrity. The Chief Operating Officer collaborates with quality assurance teams to mitigate risks and ensure regulatory compliance throughout the production lifecycle. Through rigorous oversight of industrial workflows, Sharma drives the operational excellence required to support the company's global distribution network. This commitment to manufacturing precision directly impacts the ability to deliver reliable pharmaceutical products to a vast international consumer base.
Tj Anthony - President, Generics, OTC & Business Development (US)
Tj Anthony, the President, Generics, OTC & Business Development (US) at Morepen, architects the strategic expansion of generic and OTC portfolios within the North American market. Overseeing business development initiatives, the President, Generics, OTC & Business Development (US) identifies key partnerships to accelerate market entry and product adoption. This leadership role involves navigating complex regulatory environments to secure approvals for new formulations. By fostering relationships with distributors and healthcare providers, Tj Anthony drives revenue growth and strengthens the company's competitive position in the US. The President, Generics, OTC & Business Development (US) aligns product development roadmaps with specific regional market needs to ensure long-term sustainability. Through proactive market analysis and strategic planning, Anthony secures a robust footprint for the company's pharmaceutical offerings. This focus on regional growth supports the overarching goal of expanding the global reach of high-quality healthcare products.
Kushal Suri - Growth President, International
Kushal Suri, the Growth President, International at Morepen, drives the company's expansion strategy across more than 80 countries. Overseeing international market development, the Growth President, International identifies emerging opportunities to scale the presence of APIs and finished formulations globally. This leadership role involves managing cross-border operations and ensuring alignment with diverse regulatory requirements in international territories. By cultivating strategic alliances with global distributors, Kushal Suri accelerates the penetration of the company's healthcare products into new regions. The Growth President, International coordinates with regional teams to adapt product offerings to local market demands, ensuring consistent growth and brand recognition. Through systematic market evaluation and execution of international sales strategies, Suri enhances the company's global footprint. This focus on international scalability supports the mission of providing innovative pharmaceutical solutions to a diverse and growing global consumer base.
Priti Mahwar - Chief Marketing Officer
Priti Mahwar, the Chief Marketing Officer at Morepen, directs all brand strategy and consumer engagement initiatives for the Dr. Morepen and Gubb World portfolios. Overseeing the expansion of OTC and grooming product lines, the Chief Marketing Officer ensures consistent market penetration across diverse retail channels. This leadership role involves analyzing consumer behavior to refine product positioning and maximize brand equity. By leveraging data-driven insights, Priti Mahwar optimizes marketing spend to drive revenue growth within the competitive pharmaceutical landscape. The Chief Marketing Officer coordinates with research teams to align product launches with emerging health trends. Through strategic communication and targeted advertising, Mahwar strengthens the company's market presence, ensuring that the brand remains a trusted choice for over 100 million consumers. This focus on brand excellence supports the broader mission of delivering accessible healthcare solutions globally.
Explore Leadership Teams in Manufacturing
Regeneron is a biotechnology company that discovers, develops, and commercializes innovative medicines for serious diseases. The company focuses on using advanced science and proprietary technologies to create life-changing treatments for conditions such as cancer, eye diseases, inflammatory disorders, and rare diseases.
Company Leadership
ER
GY
Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad, deep-scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred Contract Development and Manufacturing Organization (CDMO) partner for personalized medicines, blockbuster drugs and consumer health brand extensions.
Company Leadership
CH
KW
Cresco Labs is a multi-state, vertically integrated cannabis company that controls its cultivation, manufacturing, extraction, and packaging practices. Its facilities are powered by agronomists, manufacturing experts, and state-of-the-art agricultural equipment, all of which drive their commitment to quality, purity, and consistency. Cresco Labs packages, ships and distributes its products nationwide, including locations owned and operated by their team. Cresco Labs is headquartered in Chicago, Illinois.
Company Leadership CR
GB
DD
Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle. We serve our customers through a globally integrated network of facilities in North America, Europe, and Asia. This enables us to offer a comprehensive range of services including drug discovery solutions, process & pharmaceutical development services, clinical trial supplies, commercial supply of APIs, and finished dosage forms. We also offer specialized services such as the development and manufacture of highly potent APIs, antibody-drug conjugations, sterile fill/finish, peptide products & services, and potent solid oral drug product. PPS also offers development and manufacturing services for biologics including vaccines, gene therapies, and monoclonal antibodies, made possible through Piramal Pharma Limited's investment in Yapan Bio Private Limited. Our track record as a trusted service provider with experience across varied technologies we believe makes us a partner of choice for innovator and generic companies worldwide.
Company Leadership BC
SL
RM
Frequently Asked Questions Regarding Morepen Top Executives and Leadership Team
